rescue disinfectants effective against monkeypox

Rescue Line of Disinfectants Effective Against Monkeypox Virus (MPV)

Rescue Expert Blog

In cases of emerging viral pathogens such as Monkeypox Virus (MPV), when there is no test that can be conducted to validate the efficacy of a disinfectant, the EPA utilizes their Emerging Viral Pathogens Policy to determine the expected efficacy of a disinfectant against an emerging virus. In the case of an enveloped virus such as MPV, the following criteria are used to determine efficacy of a disinfectant upon enactment of the Emerging Viral Pathogens Policy:

  1. The product must be a hospital or broad-spectrum disinfectant product registered with the EPA.
  2. The product must have acceptable efficacy data previously submitted to and reviewed by the Agency against at least one non-enveloped virus, which are considered to be more resistant to disinfectants compared to enveloped viruses such as MPV.

The Rescue line of disinfectants (including Rescue Concentrate, Ready-to-Use liquid and Wipes) fulfill these criteria and therefore can be used against MPV on hard, non-porous surfaces as part of a facility’s infection prevention and control protocols.

Rescue Concentrate (EPA# 74559-4) should be applied at a 1:64 dilution for a contact time of five minutes. Rescue Ready-to-Use liquid (EPA# 74559-9) and Wipes (EPA# 74559-10) should be applied with a one-minute contact time.

To learn more about this ongoing situation as it unfolds, please refer to the CDC’s information page at the following link: